BioCareSD is the original specialty distributor, known for outstanding customer service. We feature an ever-expanding portfolio of specialty products in hemotology, immunology, neurology, orphan and other ultra-rare disease states.
Always at your service.
January 2021 PRODUCT CATALOG
1
A letter from the President
BioCareSD Partners & Friends,
Happy New Year!
Like most everyone across the globe, BioCareSD is welcoming 2021 with open arms. Over the last year our team has been extremely busy expanding our product portfolio, enhancing our facilities and developing more service offerings, all of which will deliver an even greater customer experience to you, our valued partners. As part of these enhancements, we have revamped our BioCareSD catalog and are excited to share it with you today! You will not only find a comprehensive list of all our specialty distribution products, but you’ll also find the latest news relating to any of our BioCare companies, easy links to connect with our team, and detailed information to meet your specific needs. We are proud to be one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We built our reputation on being a valued partner to our customers by delivering the best possible care to patients all over the country through our extreme agility and wide-reaching distribution capabilities.
I want to personally thank you for your ongoing trust and continued partnership with BioCareSD. I speak for the whole team when I say it is a privilege to serve you and your patients. We are always at your service.
Warm regards,
Linda Matthews President
3
What sets us apart from other specialty distributors?
BioCareSD® exists to provide fast and easy access to life-saving medications. As a trusted partner to our customers, the team at BioCareSD is relentlessly committed to expert solutions that deliver every time. Our customers are our main focus.
BioCareSD is the original specialty distributor, known for outstanding customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We feature an ever-expanding portfolio of specialty products in hemotology, immunology, neurology, orphan and other ultra-rare disease states. BioCareSD is an Authorized Distributor of Record for all the manufacturers we represent, so you can depend on the quality of our products. We are committed to being the industry’s most trusted healthcare partner by providing customer-oriented solutions, unmatched service levels and a unique distribution network to ensure the highest-quality patient care.
Staff onsite 24/7, 365 days a year
Guaranteed next-day and emergency same-day delivery
STAT and emergency deliveries are our specialty
Ability to reach anywhere in the country in 4 to 6 hours
We have an agile and wide-reaching distribution network
We are always at your service.
Spokane
Seattle
Providence
Milwaukee
Ramsey Montvale
Pittsburgh
Westbury
Dayton
Denver
Kansas City
Las Vegas
Memphis
Phoenix
El Paso
Dallas
Lafayette
Miami
5
FOR PATIENTS AT RISK OF INFECTION
Inside every brave patient living with primary humoral immunodeficiency (PI) is the desire to live the healthiest life possible. Introducing ASCENIV™, formerly known as RI-002, developed to help protect patients with PI. IT’sWHAT’s INSIDE THATCOUNTS ASCENIV™ is manufactured through a patented process using source plasma, which is acquired from donors screened using a microneutralization assay to detect and identify which donors possess naturally occurring neutralizing antibody titers to respiratory syncytial virus (RSV) 1 ◊ Plasma pool is derived from a minimum of 1000 unique donors and blends normal source plasma with RSV plasma In a 1-year, prospective, open-label, nonrandomized, multicenter, phase 3 study evaluating the efficacy and safety of ASCENIV™ in adult and pediatric patients with PI 2 : ◊ ZERO serious bacterial infections ◊ Secondary endpoint results: • 1.7 missed days of work/school/day care • <1 unscheduled medical visits • No hospitalizations †
AN igiv FOR PATIENTS WITH PRIMARY HUMORAL IMMUNODEFICIENCY (PI)
Indication ASCENIV (immune globulin intravenous, human) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Contraindications ASCENIV is contraindicated in:
Aseptic meningitis syndrome (AMS) may occur with IGIV treatments, including ASCENIV. AMS usually begins within several hours to 2 days following IGIV treatment. AMS may occur more frequently in association with high doses (2 g/kg) and/or rapid infusion of IGIV. Conduct a thorough neurological examination on patients exhibiting signs and symptoms of AMS, including cerebrospinal fluid (CSF) studies, to rule out other causes of meningitis. IGIV products, including ASCENIV, may contain blood group antibodies that can act as hemolysins and induce in vivo coating of red blood cells (RBCs) with immunoglobulin, causing a positive direct antiglobulin reaction and hemolysis. Monitor patients for clinical signs and symptoms of hemolysis, including appropriate confirmatory laboratory testing. Non-cardiogenic pulmonary edema may occur with IV administered IG. Monitor patients for pulmonary adverse reactions. If suspected, perform appropriate tests for presence of anti-neutrophil in both product and patient serum. May be managed using oxygen therapy with adequate ventilatory support. Because ASCENIV is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. All infections suspected by a physician to possibly have been transmitted by this product should be reported to ADMA Biologics at (1-800-458-4244) . After infusion of immunoglobulin, the transitory rise of the various passively transferred antibodies in the patient’s blood may yield positive serological testing results, with the potential for misleading interpretation. Passive transmission of antibodies to erythrocyte antigens (e.g., A, B, and D) may cause a positive direct or indirect antiglobulin (Coombs’) test. Adverse Reactions The most common adverse reactions to ASCENIV ( ≥ 5% of study subjects) were headache, sinusitis, diarrhea, gastroenteritis viral, nasopharyngitis, upper respiratory tract infection, bronchitis, and nausea. You are encouraged to report side effects of prescription drugs to ADMA Biologics @ 1-800-458-4244 or the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
• Patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. • IgA-deficiency patients with antibodies to IgA and a history of hypersensitivity. Warnings and Precautions Severe hypersensitivity reactions may occur with IGIV products, including ASCENIV. In case of hypersensitivity, discontinue ASCENIV infusion immediately and institute appropriate treatment. Patients with known antibodies to IgA may have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with immunoglobulin products and in the absence of known risk factors. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity and ensure adequate hydration before administration. For patients at risk of thrombosis, administer ASCENIV at the minimum dose and infusion rate practicable. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity. Acute renal dysfunction/failure, osmotic nephrosis, and death may occur upon use of human IGIV products. Ensure that patients are not volume depleted before administering ASCENIV. Periodic monitoring of renal function and urine output is particularly important in patients judged to be at increased risk of developing acute renal failure. Assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before the initial infusion of ASCENIV and at appropriate intervals thereafter. Discontinue ASCENIV if renal function deteriorates. In at risk patients, administer ASCENIV at the minimum infusion rate practicable. Hyperproteinemia, increased serum viscosity, and hyponatremia or pseudohyponatremia may occur in patients receiving IGIV treatment, including ASCENIV. It is critical to clinically distinguish true hyponatremia from a pseudohyponatremia that is associated with or causally related to hyperproteinemia. Treatment aimed at decreasing serum free water in patients with pseudohyponatremia may lead to volume depletion, a further increase in serum viscosity, and a possible predisposition to thrombotic events.
INTRODUCING
Visit asceniv.com for more information
ADMA BIOLOGICS PATENTS ISSUED 9,107,906 - 9,714,283 - 9,815,886 IGIV=immune globulin intravenous.
Important Safety Information for ASCENIV TM (Immune Globulin Intravenous [Human] – slra 10% Liquid)
WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE Thrombosis may occur with immune globulin (IGIV) products, including ASCENIV. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors. Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. ASCENIV does not contain sucrose. For patients at risk of thrombosis, renal dysfunction or renal failure, administer ASCENIV at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
Study Design: A 52-week, prospective, open-label, nonrandomized, multicenter, phase 3 study that evaluated the efficacy and safety of ASCENIV (RI-002) in 59 patients with PI. IV infusions were administered at doses of 300 to 800 mg/kg every 3 or 4 weeks. Primary efficacy endpoint was the demonstration of a serious bacterial infection (SBI) rate of less than 1.0 per person-year during the 52-week treatment period. Secondary efficacy endpoints included number of missed days of work/school/activity due to infection, unscheduled visits to the physician, and days hospitalized due to infection. 2 † One patient hospitalized from study group due to post-op local wound infection from elective surgery. For additional safety information about ASCENIV, please click here to see full Prescribing Information.
References: 1. Wasserman RL, Garcia D, Greener BN, et al. Manufacturing process optimization of ADMA Biologics’ intravenous immunoglobulin products, BIVIGAM® and ASCENIV™. Immunotherapy. 2019;11(16):1423-1433. 2. ASCENIV™ Prescribing Information, ADMA Biologics, 2019.
© 2020 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics. Visit admabiologics.com
7
Always at your service.
9
ALBUMIN PRODUCTS
HEMATOLOGY PRODUCTS
ALBUKED ALBUKED ALBUKED ALBUMIN ALBUMIN ALBUMIN ALBUMIN AP
HP
Product Category
Product Category
Subcategory
Product Name
Package Size
NDC #
Presentation
Derivation
Manufacturer
Subcategory Derivation
Package Size
NDC #
Presentation
Manufacturer
Product Name
25% 50mL 25% 100mL 5% 250mL 25% 50mL 25% 100mL 5% 250mL 5% 500mL 25% 50mL 25% 100mL 25% 50mL 25% 100mL 5% 250mL 5% 500mL 25% 20mL 5% 50mL 25% 50mL 25% 100mL 5% 250mL 5% 500mL 25% 50mL 25% 100mL 5% 250mL
76125-0784-25 Vial 76125-0784-10 Vial 76125-0790-25 Vial
Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin Albumin
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Kedrion Kedrion Kedrion
ADYNOVATE ADYNOVATE ADYNOVATE
1251 IU - 1800 IU 00944-4627-01
Vial
Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
Takeda Takeda Takeda
1251 IU - 2500 IU 00944-4625-01 Vial 2501 IU - 3200 IU 00944-4628-01 Vial
68982-0643-01
Vial
Octapharma Octapharma Octapharma Octapharma CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring
AFSTYLA AFSTYLA AFSTYLA AFSTYLA AFSTYLA AFSTYLA AFSTYLA
250 IU 500 IU 1000 IU 1500 IU 2000 IU 2500 IU 3000 IU
69911-0474-02 Vial 69911-0475-02 Vial 69911-0476-02 Vial 69911-0480-02 Vial 69911-0477-02 Vial 69911-0481-02 Vial 69911-0478-02 Vial
CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring
68982-0643-02 Vial 68982-0623-02 Vial 68982-0623-03 Vial 00053-7680-32 Vial 00053-7680-33 Vial 44206-0251-05 Vial 44206-0251-10 Vial 44206-0310-25 Vial 44206-0310-50 Vial 68516-5216-05 Vial 68516-5214-05 Vial
ALBUMINAR ALBUMINAR
ALBURX ALBURX ALBURX ALBURX
ALPHANATE
250 IU
68516-4611-01
Vial
Plasma
Grifols
ALBUTEIN ALBUTEIN ALBUTEIN ALBUTEIN ALBUTEIN ALBUTEIN FLEXBUMIN FLEXBUMIN FLEXBUMIN
Grifols Grifols Grifols Grifols Grifols Grifols Takeda Takeda Takeda
ALPHANATE
500 IU
68516-4612-01
Vial
Plasma
Grifols
68516-5216-01
Vial
68516-5216-02 Vial
68516-5214-01
Vial
ALPHANATE
1000 IU
68516-4613-02 Vial
Plasma
Grifols
68516-5214-02 Vial 00944-0493-01 Bag 00944-0493-02 Bag 00944-0495-05 Bag
ALPHANATE
1500 IU
68516-4614-02 Vial
Plasma
Grifols
HEMATOLOGY PRODUCTS
HP
ALPHANATE
2000 IU
68516-4615-02 Vial
Plasma
Grifols
Product Category
Product Name
Subcategory
Package Size
NDC #
Presentation
Derivation
Manufacturer
ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III ADVATE / ADVATE BAXJECT III
200 IU - 400 IU 00944-3051-02 Vial
Coagulation Factor VII
Recombinant
Takeda
ALPHANINE ALPHANINE ALPHANINE ALPROLIX ALPROLIX ALPROLIX ALPROLIX ALPROLIX ALPROLIX ANDEXXA
500 IU 1000 IU 1500 IU 250 IU 500 IU 1000 IU 2000 IU 3000 IU 4000 IU
68516-3607-02 Vial 68516-3608-02 Vial 68516-3609-02 Vial
Coagulation Factor IX Plasma Coagulation Factor IX Plasma Coagulation Factor IX Plasma Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor Xa Plasma Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant
Grifols Grifols Grifols
401 IU - 800 IU 00944-3052-02 Vial
Coagulation Factor VII
Recombinant
Takeda
801 IU - 1200 IU 00944-3053-02 Vial
Coagulation Factor VII
Recombinant
Takeda
71104-0966-01 71104-0911-01 71104-0922-01 71104-0933-01 71104-0944-01 71104-0977-01 69853-0102-01
Vial Vial Vial Vial Vial Vial
BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ
1201 IU - 1800 IU 00944-3054-02 Vial
Coagulation Factor VII
Recombinant
Takeda
1801 IU - 2400 IU 00944-3045-10 Vial
Coagulation Factor VII
Recombinant
Takeda
2401 IU - 3600 IU 00944-3046-10 Vial
Coagulation Factor VII
Recombinant
Takeda
200 mg Vial
Carton: 4 vials/CTN
Portola Pharmaceuticals
3601 IU - 4800 IU 00944-3047-10 Vial
Coagulation Factor VII
Recombinant
Takeda
BENEFIX BENEFIX BENEFIX BENEFIX BENEFIX
250 IU 500 IU
58394-0633-03 Vial 58394-0634-03 Vial 58394-0635-03 Vial 58394-0636-03 Vial 58394-0637-03 Vial
Pfizer Pfizer Pfizer Pfizer Pfizer
ADYNOVATE ADYNOVATE ADYNOVATE ADYNOVATE
200 IU - 400 IU 00944-4622-01 401 IU - 800 IU 00944-4623-01
Vial Vial
Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII Coagulation Factor VII
Recombinant Recombinant Recombinant Recombinant
Takeda Takeda Takeda Takeda
1000 IU 2000 IU 3000 IU
600 IU - 938 IU 00944-4626-01 Vial 801 IU - 1250 IU 00944-4624-01 Vial
11
HEMATOLOGY PRODUCTS
HEMATOLOGY PRODUCTS
HP
HP HEMOFIL HEMOFIL HUMATE-P
Product Category
Product Category
Subcategory Derivation
Subcategory Derivation
Package Size
NDC #
Presentation
Manufacturer
Package Size
NDC #
Presentation
Manufacturer
Product Name
Product Name
CABLIVI
11 mg
58468-0225-01
Vial
Coagulation von
Recombinant
Genzyme
801 IU – 1700 IU 00944-3944-02 Vial 1501 IU – 2000 IU 00944-3946-02 Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor Coagulation Factor VIII with von Willebrand Factor
Plasma Plasma Plasma
Takeda Takeda
Willebrand Factor
600 RCOF
63833-0615-02 Vial
CSL Behring
COAGADEX COAGADEX CORIFACT ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ELOCTATE ESPEROCT ESPEROCT ESPEROCT ESPEROCT ESPEROCT
250 IU 500 IU 1000 IU 250 IU 500 IU 750 IU 1000 IU 1500 IU 2000 IU 3000 IU 4000 IU 5000 IU 6000 IU 500 IU 1000 IU 1500 IU 2000 IU 3000 IU
64208-7752-01 64208-7753-01
Vial Vial
Coagulation Factor X Plasma Coagulation Factor X Plasma
BPL BPL
63833-0518-02 Vial
Coagulation Factor XIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor
Plasma
CSL Behring BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ BioVerativ Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk
HUMATE-P
1200 RCOF
63833-0616-02 Vial
Plasma
CSL Behring
71104-0801-01 71104-0802-01 71104-0803-01 71104-0804-01 71104-0805-01 71104-0806-01 71104-0807-01 71104-0808-01 71104-0809-01 71104-0810-01 00169-8500-01 00169-8100-01 00169-8150-01 00169-8200-01 00169-8300-01
Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
HUMATE-P
2400 RCOF
63833-0617-02 Vial
Plasma
CSL Behring
IDELVION IDELVION IDELVION IDELVION IDELVION IDELVION
250 IU 500 IU
69911-0864-02 0 69911-0865-02 0 69911-0866-02 0 69911-0867-02 0 69911-0868-02 Vial 69911-0869-02 Vial 00026-3942-25 Vial 00026-3944-25 Vial 00026-3946-25 Vial 00026-3948-25 Vial 63833-0386-02 Vial
Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant
CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring
1000 IU 2000 IU 3000 IU 4000 IU 500 IU 1000 IU 2000 IU 3000 IU
JIVI / JIVI-500 JIVI / JIVI-1000 JIVI / JIVI-2000 JIVI / JIVI-3000
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor
Recombinant Recombinant Recombinant Recombinant
Bayer Bayer Bayer Bayer
FEIBA
500 IU
64193-0426-02 Vial
Plasma
Takeda
Complex
FEIBA
1000 IU
64193-0424-02 Vial
Coagulation Factor
Plasma
Takeda
KCENTRA
500 IU
Plasma
CSL Behring
Complex
Complex
FEIBA
2000 IU
64193-0425-02 Vial
Coagulation Factor
Plasma
Takeda
KCENTRA
1000 IU
63833-0387-02 Vial
Coagulation Factor
Plasma
CSL Behring
Complex
Complex
FIBRYGA Hemlibra
1 Gram 30 mg
68982-0347-01 50242-0920-01
Vial Vial
Coagulation Factor I Coagulation Anti-
Plasma
Octapharma Genentech Inc
KOATE-DVI KOATE-DVI KOATE-DVI KOGENATE KOGENATE KOGENATE KOGENATE KOGENATE KOVALTRY KOVALTRY KOVALTRY KOVALTRY KOVALTRY MONONINE NOVOEIGHT NOVOEIGHT NOVOEIGHT
250 IU 500 IU 1000 IU 250 IU 500 IU 1000 IU 2000 IU 3000 IU
76125-0256-20 Vial 76125-0668-30 Vial 76125-0676-50 Vial 00026-3782-25 Vial 00026-3783-35 Vial 00026-3785-55 Vial 00026-3786-65 Vial 00026-3787-75 Vial 00026-3821-25 0 00026-3822-25 0 00026-3824-25 0 00026-3826-50 0 00026-3828-50 0 00053-6233-02 Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Plasma Plasma Plasma
Kedrion Kedrion Kedrion
Monoclonal Antibody
Inhibitor Coagulant Complex
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
Bayer Bayer Bayer Bayer Bayer Bayer Bayer Bayer Bayer Bayer
Hemlibra
60 mg
50242-0921-01
Vial
Coagulation Anti-
Monoclonal Antibody
Genentech Inc
Inhibitor Coagulant Complex
Hemlibra
105 mg
50242-0922-01
Vial
Coagulation Anti-
Monoclonal Antibody
Genentech Inc
250 IU 500 IU
Inhibitor Coagulant Complex
1000 IU 2000 IU 3000 IU 1000 IU 250 IU 500 IU 1000 IU
Hemlibra
150 mg
50242-0923-01
Vial
Coagulation Anti-
Monoclonal Antibody
Genentech Inc
Inhibitor Coagulant Complex
Coagulation Factor IX Plasma
CSL Behring Novo Nordisk Novo Nordisk Novo Nordisk
00169-7825-01 00169-7850-01 00169-7810-01
Vial Vial Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Recombinant Recombinant Recombinant
HEMOFIL HEMOFIL
220 IU – 400 IU 00944-3940-02 Vial 401 IU – 800 IU 00944-3942-02 Vial
Coagulation Factor VIII Coagulation Factor VIII
Plasma Plasma
Takeda Takeda
13
HEMATOLOGY PRODUCTS
HEMATOLOGY PRODUCTS
HP
XYNTHA XYNTHA XYNTHA XYNTHA XYNTHA XYNTHA HP
Product Category
Product Category
Product Name
Product Name
Subcategory
Subcategory
Package Size
NDC #
Presentation
Derivation
Manufacturer
Package Size
NDC #
Presentation
Derivation
Manufacturer
250 IU 500 IU
58394-0012-01 58394-0013-01 58394-0014-01 58394-0015-01 58394-0012-01 58394-0013-01
Vial Vial Vial Vial Vial Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer Pfizer
NOVOEIGHT NOVOEIGHT NOVOEIGHT
1500 IU 2000 IU 3000 IU
00169-7815-01 00169-7820-01 00169-7830-01 00169-7201-01 00169-7202-01 00169-7205-01 00169-7208-01 68982-0139-01 68982-0141-01 68982-0143-01 68982-0145-01 68982-0147-01 68982-0149-01 68982-0151-01
Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Recombinant Recombinant Recombinant
Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma
1000 IU 2000 IU
NOVOSEVEN RT NOVOSEVEN RT NOVOSEVEN RT NOVOSEVEN RT
1 mg 2 mg 5 mg 8 mg
Coagulation Factor VIIa Recombinant Coagulation Factor VIIa Recombinant Coagulation Factor VIIa Recombinant Coagulation Factor VIIa Recombinant
250 IU 500 IU 250 IU 500 IU
XYNTHA SOLOFUSE XYNTHA SOLOFUSE XYNTHA SOLOFUSE XYNTHA SOLOFUSE XYNTHA SOLOFUSE
58394-0022-03 Vial 58394-0023-03 Vial 58394-0024-03 Vial 58394-0025-03 Vial 58394-0016-03 Vial
NUWIQ NUWIQ NUWIQ NUWIQ NUWIQ NUWIQ NUWIQ OBIZUR
250 IU 500 IU
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
1000 IU 2000 IU 3000 IU
1000 IU 2000 IU 2500 IU 3000 IU 4000 IU
IMMUNOLOGY PRODUCTS - HYPERIMMUNE GLOBULIN
HG
1-PACK 500 AU 00944-5001-01
Takeda Grifols Grifols Grifols
Product Category
PROFILNINE PROFILNINE PROFILNINE REBINYN 500 REBINYN 1000 REBINYN 2000 RECOMBINATE RECOMBINATE RECOMBINATE RECOMBINATE RECOMBINATE
500 IU 1000 IU 1500 IU 500 IU 1000 IU 2000 IU
68516-3207-01
Coagulation Factor IX Plasma Coagulation Factor IX Plasma Coagulation Factor IX Plasma
Subcategory Derivation
Package Size
NDC #
Presentation
Manufacturer
Product Name
68516-3208-02 Vial 68516-3209-02 Vial
GAMASTAN S/D
2 ml
13533-0635-04 Vial
Hyperimmune Globulin Hyperimmune Globulin
Hepatitis A N/A
Grifols
00169-7905-01 00169-7901-01 00169-7902-01
Vial Vial Vial
Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII Coagulation Factor VIII
Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant Recombinant
Novo Nordisk Novo Nordisk Novo Nordisk
GAMASTAN S/D
10 ml
13533-0635-12 Vial
Hepatitis A N/A
Grifols
HEPAGAM HEPAGAM
1 mL 5 mL
70257-0052-51 70257-0051-51
Vial Vial
IVIG IVIG
RH Immune N/A RH Immune N/A RH Immune N/A
Grifols Grifols Grifols
220 IU – 400 IU 00944-2841-10 Vial 401 IU – 800 IU 00944-2842-10 Vial 801 IU – 1240 IU 00944-2843-10 Vial 1241-1800 IU 00944-2844-10 Vial 1801 – 2400 IU 00944-2845-10 Vial
Takeda Takeda Takeda Takeda Takeda Takeda Takeda Takeda Takeda Takeda Grifols
HYPERRHO S/D
1500 IU
13533-0631-02 Vial
Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin Hyperimmune Globulin
HYPERTET S/D
250 IU
13533-0634-02 Syringe
Tetanus
N/A
Grifols
MICRHOGAM
1 PACK
00562-7806-01
Syringe
RH Immune N/A
Kedrion
RIXUBIS RIXUBIS RIXUBIS RIXUBIS RIXUBIS
250 IU 500 IU
00944-3026-02 Vial 00944-3028-02 Vial 00944-3030-02 Vial 00944-3032-02 Vial 00944-3034-02 Vial 13533-0602-50 Vial
Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant Coagulation Factor IX Recombinant
NABI-HB
5 ml
69800-4203-01
Vial
RH Immune N/A
ADMA Biologics Kedrion
1000 IU 2000 IU 3000 IU
RHOGAM
1 PACK
00562-7805-01
Syringe
RH Immune N/A
THROMBATE III
500 IU
Coagulation Anti-
Plasma
RHOPHYLAC
300 mcg
44206-0300-10 Pack, 10 syringes
RH Immune N/A
CSL Behring
Thrombin
VONVENDI
450 – 850 IU 00944-7551-02 Vial
Coagulation von
Recombinant
Takeda
WINRHO SDF LIQUID 300 ug (1500 IU) 70504-3300-02 Vial
RH Immune N/A
Saol Therapeutics Saol Therapeutics Saol Therapeutics
Willebrand Factor
WINRHO SDF LIQUID 500 ug (2500 IU) 70504-3500-02 Vial
RH Immune N/A
VONVENDI
900 – 1700 IU 00944-7553-02 Vial
Coagulation von
Recombinant
Takeda
Willebrand Factor
WINRHO SDF LIQUID 1000 ug (5000 IU) 70504-3100-02 Vial
RH Immune N/A
WILATE
500 RCOF
68982-0182-01
Vial
Coagulation von
Plasma
Octapharma
Willebrand Factor
WILATE
1000 RCOF
68982-0182-02 Vial
Coagulation von
Plasma
Octapharma
Willebrand Factor
15
IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN
IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN
IG
IG
Product Category
Product Category
Product Name
Subcategory Derivation
Subcategory Derivation
Package Size
NDC #
Presentation
Manufacturer
Package Size
NDC #
Presentation
Manufacturer
Product Name
ASCENIV
5 Gram
69800-0250-01 Vial
IVIG
N/A
N/A
ADMA Biologics ADMA Biologics
HYQVIA HYQVIA HYQVIA HYQVIA
5 Gram 10 Gram 20 Gram 30 Gram
00944-2511-02 Vial 00944-2512-02 Vial 00944-2513-02 Vial 00944-2514-02 Vial
IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Takeda Takeda Takeda Takeda
BIVIGAM
5 Gram
69800-6502-01
Vial
IVIG
N/A
N/A
CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG CUTAQUIG
1 Gram 2 Gram 4 Gram 8 Gram 1 Gram 2 Gram 4 Gram 8 Gram
68982-0810-01
Vial
IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG IVIG
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Octapharma Octapharma Octapharma Octapharma
OCTAGAM 5% OCTAGAM 5% OCTAGAM 5% OCTAGAM 5% OCTAGAM 10% OCTAGAM 10% OCTAGAM 10% OCTAGAM 10% OCTAGAM 10%
1% 5 Gram
68982-0840-01
Vial
Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma Octapharma
68982-0810-03 Vial 68982-0810-05 Vial 68982-0810-06 Vial 00069-1061-02 Vial 00069-1476-02 Vial 00069-1509-02 Vial 00069-1965-02 Vial 00944-2700-02 Vial 00944-2700-03 Vial 00944-2700-04 Vial 00944-2700-05 Vial 00944-2700-06 Vial 00944-2700-07 Vial 00944-2656-03 Vial 00944-2658-04 Vial
2.5% 5 Gram 68982-0840-02 Vial
5% 5 Gram
68982-0840-03 Vial
5% 10 Gram 68982-0840-04 Vial
Pfizer Pfizer Pfizer Pfizer
10% 2 Gram 68982-0850-01
Vial
10% 5 Gram 68982-0850-02 Vial 10% 10 Gram 68982-0850-03 Vial 10% 20 Gram 68982-0850-04 Vial 10% 30 Gram 68982-0850-05 Vial
GAMMAGARD LIQUID 1 Gram GAMMAGARD LIQUID 2.5 Gram GAMMAGARD LIQUID 5 Gram GAMMAGARD LIQUID 10 Gram GAMMAGARD LIQUID 20 Gram GAMMAGARD LIQUID 30 Gram GAMMAGARD S/D 5 Gram GAMMAGARD S/D 10 Gram
Takeda Takeda Takeda Takeda Takeda Takeda Takeda Takeda Kedrion Kedrion Kedrion Kedrion
PANZYGA PANZYGA PANZYGA PANZYGA PANZYGA PRIVIGEN PRIVIGEN PRIVIGEN PRIVIGEN XEMBIFY XEMBIFY XEMBIFY XEMBIFY
2.5 Gram 5 Gram 10 Gram 20 Gram 30 Gram 5 Gram 10 Gram 20 Gram 40 Gram 1 Gram 2 Gram 4 Gram 10 Gram
68982-0820-02 Vial 68982-0820-03 Vial 68982-0820-04 Vial 68982-0820-05 Vial 68982-0820-06 Vial 44206-0436-05 Vial 44206-0437-10 Vial 44206-0438-20 Vial 44206-0439-40 Vial 13533-0810-05 Vial 13533-0810-10 Vial 13533-0810-20 Vial 13533-0810-50 Vial
Pfizer Pfizer Pfizer Pfizer Pfizer
CSL Behring CSL Behring CSL Behring CSL Behring
GAMMAKED GAMMAKED GAMMAKED GAMMAKED GAMMAPLEX GAMMAPLEX GAMMAPLEX GAMMAPLEX GAMMAPLEX GAMMAPLEX GAMUNEX-C GAMUNEX-C GAMUNEX-C GAMUNEX-C GAMUNEX-C GAMUNEX-C
1 Gram 5 Gram
76125-0900-01
Vial
76125-0900-50 Vial 76125-0900-10 Vial 76125-0900-20 Vial 64208-8234-06 Vial
10 Gram 20 Gram
Grifols Grifols Grifols Grifols
5% 5 Gram
BPL BPL BPL BPL BPL BPL
10% 5 Gram 64208-8235-05 Vial 5% 10 Gram 64208-8234-07 Vial 10% 10 Gram 64208-8235-06 Vial 10% 20 Gram 64208-8235-07 Vial 5% 20 Gram 64208-8234-08 Vial
NEUROLOGY PRODUCTS Package Size NDC # Product Name
NP RADICAVA
Product Category
Subcategory Derivation
Presentation
Manufacturer
1 Gram
13533-0800-12 Vial 13533-0800-15 Vial 13533-0800-20 Vial
Grifols Grifols Grifols Grifols Grifols Grifols
2.5 Gram 5 Gram 10 Gram 20 Gram 40 Gram 1 Gram 2 Gram 4 Gram 10 Gram 1 Gram 2 Gram 4 Gram 2.5 Gram
30MG/100 mL
70510-2171-02 Carton
Specialty
N/A
N/A
Mitsubishi TPA
13533-0800-71
Vial
13533-0800-24 Vial 13533-0800-40 Vial
HIZENTRA HIZENTRA HIZENTRA HIZENTRA
44206-0451-01
Vial
CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring CSL Behring
44206-0452-02 Vial 44206-0454-04 Vial 44206-0455-10 Vial
HIZENTRA PFS HIZENTRA PFS HIZENTRA PFS
44206-0456-21
Vial
44206-0457-22 Vial 44206-0458-24 Vial 00944-2510-02 Vial
HYQVIA
Takeda
17
SPECIALTY PRODUCTS
SP Product Name
Product Category
Subcategory Derivation
Package Size
NDC #
Presentation
Manufacturer
Interested in having your ad featured in our catalog? Contact marketing@biocare sd .com to learn more!
ANAVIP
1 Carton = 1 vial
Specialty Specialty
Anti-Venom N/A
RDT Inc
66621-0790- 0 2 Vial 63833-0825-02 Vial
N/A
CSL Behring
BERINERT
500 Units
Hereditary Angioderma Protein C Deficiency Protein C Deficiency
CEPROTIN
500 IU
00944-4177-05 Vial
Specialty
N/A
Takeda
CEPROTIN
1000 IU
00944-4179-10 Vial
Specialty
N/A
Takeda
CROFAB
2 ml
50633-0110-12 Carton, 2 vials per
Specialty
Anti-Venom N/A
BTG
CYTOGAM
2.5 Grams
44206-0532-11
Vial
Specialty
N/A
CSL Behring
Cytomegalovirus
ENGERIX-B
1 ml
58160-0821-10 Pack, 10 vials per 64764-0300-20 Vial 13533-0618-10 Vial 13533-0618-02 Vial 76125-0150-10 Vial 76125-0150-02 Vial
Specialty
Vaccine
N/A
GlaxoSmithKline
Download Media Kit
ENTYVIOO
300mg 20mL
Specialty
N/A
Monoclonal Antibody
Takeda
HYPERRAB HYPERRAB
10 ml
Specialty Specialty Specialty Specialty Specialty
Rabies Rabies Rabies Rabies
N/A N/A N/A N/A N/A
Grifols Grifols Kedrion Kedrion
2 ml
KEDRAB KEDRAB RIASTAP
10 ml
2 ml
1000 IU
63833-0891-51
Vial
Fibrinogen Deficiency
CSL Behring
SOLIRIS TISSEEL
300mg/ml
25682-0001-01
Vial
Specialty Specialty
N/A
N/A N/A
Alexion
2 mL
00338-4301-02 Each
Sealant
Baxter- BioSurgery Baxter- BioSurgery Baxter- BioSurgery Baxter- BioSurgery Baxter- BioSurgery Baxter- BioSurgery
TISSEEL
4 mL
00338-4302-04 Each
Specialty
Sealant
N/A
TISSEEL
10 mL
00338-4303-10 Each
Specialty
Sealant
N/A
TISSEEL
FROZEN 2 mL
00944-8402-02 Each
Specialty
Sealant
N/A
TISSEEL
FROZEN 4 mL
00944-8402-04 Each
Specialty
Sealant
N/A
TISSEEL
FROZEN 10 mL
00944-8402-10 Each
Specialty
Sealant
N/A
19
People who care.
Our team at BioCare is committed to being your most trusted partner. We get the right products in the right hands at the right time, no matter what it takes. We are proud to support our partners in their mission to save lives.
Always at your service.
We care for you.
Delivering care daily.
21
January 2021 PRODUCT CATALOG
Always at your service.
www.biocaresd.com 2826 South Potter Drive Tempe, AZ 85282
Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22Powered by FlippingBook